CANCER-ID
CANCER-ID
20/12/2016

Exciting news

Menarini Silicon Biosystems to buy CellSearch® System

Menarini-Silicon Biosystems today announced they have signed an agreement to purchase all the assets and relevant business related to the CELLSEARCH® Circulating Tumor Cell (CTC) system from Janssen Diagnostics, LLC.  CELLSEARCH is used to help manage patients with metastatic breast, prostate, and colorectal cancers. It is the only FDA-cleared CTC test, and has also been approved by China's FDA for use in monitoring breast cancer patients.

Fore more information please click here.

EUROPA - NEWS

News from the European Comission

What's new in Health and Life Sciences? Click here for news from the European Commission.

Search
Top
Home
Menu

EU logo
imi Logo
efpia Logo

News Section

The main goal of the ELBS is to foster the introduction of liquid biopsy into...

Read more

Social Media

LinkedIn Cancer-ID